Menu
Enrolling by invitation NCT07338825

Prevalence of Functional Ankle Instability Among Professional Egyptian Players: a Cross-sectional Study

Observational Ankle Instability

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Ankle Instability. Basic parameters: 8 years — 35 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

To investigate the prevalence of functional ankle instability among professional Egyptian soccer players

Primary outcome measures

  • Prevalence of functional ankle instability among professional Egyptian soccer players [Time frame: 4 months]

Eligibility criteria

Inclusion criteria

  • 1\. Three Hundred Soccer players from both genders aged between 8-35 years old including junior teams (8-12 years old), Youth (13-20 years old) and Senior teams (21,>21 years old).

2\. Players have BMI 18-25 (kg/m²). 3. Players are registered in the Egyptian Soccer Association

Exclusion criteria

  • 1- Systematic pathology that affects balance, reflexes, or muscle strength 2- Lower limb fractures in the 2 years preceding the study 3- Surgery on one of the ankles 4- Structural malalignments 5- Plantar Fasciitis

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Other

Study locations

Egypt · 1 center
  • Cairo university — Cairo

Identifiers

NCT: NCT07338825 · P.T.REC/012/006046

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗